Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,872 | 11,666 | 32,362 | 33,689 | 39,483 |
| Marketable Securities | 13,798 | 20,472 | N/A | N/A | N/A |
| Receivables | 730 | 521 | 497 | 356 | 102 |
| TOTAL | $34,261 | $35,684 | $38,205 | $39,407 | $43,536 |
| Non-Current Assets | |||||
| PPE Net | 840 | 652 | 754 | 832 | 911 |
| Other Non-Current Assets | 227 | 998 | 0 | 0 | 0 |
| TOTAL | $1,067 | $1,650 | $754 | $832 | $911 |
| Total Assets | $35,328 | $37,334 | $38,959 | $40,239 | $44,446 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | N/A | 2,252 | N/A | N/A | N/A |
| Accrued Expenses | N/A | 1,398 | N/A | N/A | N/A |
| Other current liabilities | 48 | 79 | 50 | 31 | 68 |
| TOTAL | $2,469 | $3,945 | $3,666 | $2,544 | $2,424 |
| Non-Current Liabilities | |||||
| TOTAL | $7,108 | $6,887 | $6,896 | $6,922 | $7,007 |
| Total Liabilities | $9,577 | $10,832 | $10,562 | $9,466 | $9,431 |
| Shareholders' Equity | |||||
| Common Shares | 409,412 | 404,040 | 398,068 | 396,807 | 396,504 |
| Retained earnings | -424,688 | -418,251 | -409,696 | -405,289 | -400,194 |
| Other shareholders' equity | 659 | 662 | 723 | 453 | 3,958 |
| TOTAL | $25,751 | $26,502 | $28,397 | $30,773 | $35,015 |
| Total Liabilities And Equity | $35,328 | $37,334 | $38,959 | $40,239 | $44,446 |